MAP/microtubule Affinity-Regulating Kinase 3 (MARK3) (Middle Region) Peptide
MARK3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all MARK3 products
- MARK3 (MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MARK3 antibody (Catalog #: ARP56343_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MARK3 (MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
- Background
-
MARK3 is involved in the specific phosphorylation of microtubule-associated proteins for tau, MAP2 and MAP4. Phosphorylates CDC25C on 'Ser-216'.
Alias Symbols: CTAK1, KP78, PAR1A, Par-1a
Protein Interaction Partner: ANKRD7,ASB13,ATP6V0C,CDC25C,CHGB,CPSF4,DYNLL1,FANCF,KSR1,NOL11,PKP2,PMPCB,PNPLA2,PRKCQ,SAAL1,SFN,TCEA2,TTR,VPS11,YWHAG,YWHAZ,ATP6V0C,CHGB,MARK2,PMPCB,PNPLA2,RASGRF1,SAAL1,SFN,TCEA2,TTR,UBC,USP21,VPS11,YWHAB,YWHAG,YWHAQ
Protein Size: 729 - Molecular Weight
- 81 kDa
- Gene ID
- 4140
- NCBI Accession
- NM_002376, NP_002367
-
You are here:
